Amyris, Inc. (Nasdaq: AMRS) announced that it has signed its first Biofene ingredient supply agreement for the global nutraceuticals and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE